Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v2-FR
Language English French
Date Updated 2022-12-22 2022-12-07
Drug Identification Number 02301490 02301490
Brand name CYMBALTA CYMBALTA
Common or Proper name Duloxetine hydrochloride delayed release capsules Duloxetine hydrochloride delayed release capsules
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients DULOXETINE DULOXETINE
Strength(s) 60MG 60MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size Carton containing 28 capsules in blister packaging Carton containing 28 capsules in blister packaging
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-05 2022-12-05
Estimated end date 2022-12-22 2022-12-22
Actual end date 2022-12-22
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments